This report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing or marketing innovative technologies, products, and applications. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
|